These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35694932)

  • 41. Limb-girdle congenital myasthenic syndrome in a Chinese family with novel mutations in MUSK gene and literature review.
    Luan X; Tian W; Cao L
    Clin Neurol Neurosurg; 2016 Nov; 150():41-45. PubMed ID: 27588369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful treatment of congenital myasthenic syndrome caused by a novel compound heterozygous variant in RAPSN.
    Saito M; Ogasawara M; Inaba Y; Osawa Y; Nishioka M; Yamauchi S; Atsumi K; Takeuchi S; Imai K; Motobayashi M; Misawa Y; Iida A; Nishino I
    Brain Dev; 2022 Jan; 44(1):50-55. PubMed ID: 34565654
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical and molecular genetic study on two patients of the juvenile form of Pompe disease in China].
    Qiu JJ; Wei M; Zhang WM; Shi HP
    Zhonghua Er Ke Za Zhi; 2007 Oct; 45(10):760-4. PubMed ID: 18211760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenic DPAGT1 variants in limb-girdle congenital myasthenic syndrome (LG-CMS) associated with tubular aggregates and ORAI1 hypoglycosylation.
    Brande LV; Bauché S; Pérez-Guàrdia L; Sternberg D; Seferian AM; Malfatti E; Silva-Rojas R; Labasse C; Chevessier F; Carlier P; Eymard B; Romero NB; Laporte J; Servais L; Gidaro T; Böhm J
    Neuropathol Appl Neurobiol; 2023 Dec; ():e12952. PubMed ID: 38124360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Congenital myasthenic syndrome: Correlation between clinical features and molecular diagnosis.
    Estephan EP; Zambon AA; Thompson R; Polavarapu K; Jomaa D; Töpf A; Helito PVP; Heise CO; Moreno CAM; Silva AMS; Kouyoumdjian JA; Morita MDP; Reed UC; Lochmüller H; Zanoteli E
    Eur J Neurol; 2022 Mar; 29(3):833-842. PubMed ID: 34749429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States.
    Reddy HM; Cho KA; Lek M; Estrella E; Valkanas E; Jones MD; Mitsuhashi S; Darras BT; Amato AA; Lidov HG; Brownstein CA; Margulies DM; Yu TW; Salih MA; Kunkel LM; MacArthur DG; Kang PB
    J Hum Genet; 2017 Feb; 62(2):243-252. PubMed ID: 27708273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Congenital myasthenic syndrome caused by a frameshift insertion mutation in
    Szelinger S; Krate J; Ramsey K; Strom SP; Shieh PB; Lee H; Belnap N; Balak C; Siniard AL; Russell M; Richholt R; Both M; Claasen AM; Schrauwen I; Nelson SF; Huentelman MJ; Craig DW; Yang SP; Moore SA; Sivakumar K; Narayanan V; Rangasamy S;
    Neurol Genet; 2020 Aug; 6(4):e468. PubMed ID: 32754643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.
    Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A
    Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis of DOK7 congenital myasthenic syndrome during pregnancy: A case report and literature review.
    Fernandes M; Caetano A; Pinto M; Medeiros E; Santos L
    Clin Neurol Neurosurg; 2021 Apr; 203():106591. PubMed ID: 33714798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A retrospective study of six patients with late-onset Pompe disease].
    Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
    Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathological-genetic features of congenital myasthenic syndrome from a Chinese neuromuscular centre.
    Huang K; Duan HQ; Li QX; Luo YB; Bi FF; Yang H
    J Cell Mol Med; 2022 Jul; 26(14):3828-3836. PubMed ID: 35670010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect.
    Senderek J; Müller JS; Dusl M; Strom TM; Guergueltcheva V; Diepolder I; Laval SH; Maxwell S; Cossins J; Krause S; Muelas N; Vilchez JJ; Colomer J; Mallebrera CJ; Nascimento A; Nafissi S; Kariminejad A; Nilipour Y; Bozorgmehr B; Najmabadi H; Rodolico C; Sieb JP; Steinlein OK; Schlotter B; Schoser B; Kirschner J; Herrmann R; Voit T; Oldfors A; Lindbergh C; Urtizberea A; von der Hagen M; Hübner A; Palace J; Bushby K; Straub V; Beeson D; Abicht A; Lochmüller H
    Am J Hum Genet; 2011 Feb; 88(2):162-72. PubMed ID: 21310273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Late-onset Pompe disease: what is the prevalence of limb-girdle muscular weakness presentation?
    Lorenzoni PJ; Kay CSK; Higashi NS; D'Almeida V; Werneck LC; Scola RH
    Arq Neuropsiquiatr; 2018 Apr; 76(4):247-251. PubMed ID: 29742245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Late Onset Pompe Disease with Novel Mutations and Atypical Phenotypes.
    Chawla T; Preethish-Kumar V; Polavarapu K; Vengalil S; Bardhan M; Puri R; Verma J; Christopher R; Supriya M; Nashi S; Prasad C; Nadeesh B; Nalini A
    J Neuromuscul Dis; 2022; 9(2):261-273. PubMed ID: 34864681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Congenital myasthenic syndrome caused by mutations in DPAGT.
    Klein A; Robb S; Rushing E; Liu WW; Belaya K; Beeson D
    Neuromuscul Disord; 2015 Mar; 25(3):253-6. PubMed ID: 25500013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
    Tsao CY
    Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Next generation deep sequencing corrects diagnostic pitfalls of traditional molecular approach in a patient with prenatal onset of Pompe disease.
    Tsai AC; Hung YW; Harding C; Koeller DM; Wang J; Wong LC
    Am J Med Genet A; 2017 Sep; 173(9):2500-2504. PubMed ID: 28657663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reevaluating the pathogenicity of the mutation c.1194 +5 G>A in GAA gene by functional analysis of RNA in a 61-year-old woman diagnosed with Pompe disease by muscle biopsy.
    Amiñoso C; Gordillo-Marañón M; Hernández J; Solera J
    Neuromuscul Disord; 2019 Mar; 29(3):187-191. PubMed ID: 30770309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Congenital myasthenic syndromes in adult neurology clinic: A long road to diagnosis and therapy.
    Kao JC; Milone M; Selcen D; Shen XM; Engel AG; Liewluck T
    Neurology; 2018 Nov; 91(19):e1770-e1777. PubMed ID: 30291185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pompe disease: pathogenesis, molecular genetics and diagnosis.
    Taverna S; Cammarata G; Colomba P; Sciarrino S; Zizzo C; Francofonte D; Zora M; Scalia S; Brando C; Curto AL; Marsana EM; Olivieri R; Vitale S; Duro G
    Aging (Albany NY); 2020 Aug; 12(15):15856-15874. PubMed ID: 32745073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.